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Tumorigenicity andmetastatic activity can be visually monitored in cancer cells that were labelled with stable fluorescence.The aim
was to establish and validate local and distant spread of subcutaneously previously injected fluorescence transduced human tongue
cancer cell lines of epithelial and mesenchymal phenotype in nude mice. A total of 32 four-week-old male athymic Balb/c nude
mice were randomly allocated into 4 groups (𝑛 = 8). A single dose of 0.3mL PBS containing 1 × 107 of four different cancer cell-
lines (UM1, UM1-GFP, UM2, and UM2-RFP) was injected subcutaneously into the right side of their posterolateral back. Validity
assessment of the labelled cancer cells’ tumorigenicity was assessed by physical examination, imaging, and histology fourweeks after
the injection. The tumor take rate of cancer cells was similar in animals injected with either parental or transduced cancer cells.
Transduced cancer cells in mice were easily detectable in vivo and after cryosection using fluorescent imaging. UM1 cells showed
increased tumor take rate and mean tumor volume, presenting with disorganized histopathological patterns. Fluorescence labelled
epithelial andmesenchymal human tongue cancer cell lines do not change in tumorigenicity or cell phenotype after injection in vivo.
1. Introduction
A fluorescent labelling of human oral cancer cell lines, stable
over several generations, might provide the possibility to
visually monitor their tumorigenicity and metastatic activity
in vivo.
Both green fluorescent protein (GFP) and red fluorescent
protein (RFP) (GenTarget, Inc., San Diego, USA) have been
extensively used to study cancer biology in animal models
due to their stability after transduction [1]. As transduced
cancer cells and their daughter cells persistently expressed the
fluorescent proteins, a direct long-term visualization in vivo
became facilitated [2–4].
In mice GFP/RFP labelled murine cancer cell lines were
used to study the role of epithelial mesenchymal transition
(EMT) in distant metastasis; it was detected that cells of
epithelial and mesenchymal phenotype showed a fair share
in the formation of distant metastasis [5]. The same authors,
however, did not comment on an earlier report regarding
negative effects of GFP transduction onto long-term devel-
opment of colon cancer micro- and macrometastases in mice
[1].
Cancer metastasis and local cancer invasion are consid-
ered to be closely related to specific cell phenotypes and
their dynamic transition [6–8]. A negative in vitro interaction
between GFP/RFP transduction and epithelial and/or mes-
enchymal phenotypes of human tongue cancer cell lines UM1
and UM2 has already been excluded previously, where it was
detected that transduced UM1-GFP and UM2-RFP human
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tongue cancer cell lines maintained their particular original
cell phenotype (Cai et al. in press).
Still, verification is needed, if those in vitro findings for
transduced human cancer cells mentioned above also prevail
in vivo in hairless “nude” mice.This particular animal model
is appropriate (1) for subcutaneous tumor implantation and
its subsequent clinical assessment [9] and (2) to detect fluo-
rescence expressing cancer cells in living animals bymeans of
specific intravital imaging techniques [10].
This study aimed to establish and validate a novel in vivo
nude mice model where subcutaneously injected transduced
human tongue cancer cell lines of epithelial andmesenchymal
phenotype could be visualized under a fluorescent micro-
scope.
2. Materials and Methods
2.1. Cell Culture. The GFP/RFP transduction procedure and
cell culture conditions were described in our previous publi-
cation (Cai et al. in press). In brief, two human tongue cancer
cell lines UM1 and UM2 (donation from Dr. David Wong,
School of Dentistry, University of California Los Angeles,
USA) were cultured in an incubator at 37∘C/5% CO
2
using
DMEM/F-12 medium (DMEM/F-12, a mixture of Dulbecco’s
Modified Eagle Medium and Ham’s F-12 medium at 1 : 1,
Sigma, New York, NY, USA). UM1 and UM2 demonstrated
mesenchymal and epithelial cell features, respectively. GFP
andRFP lentiviral particles stock (GenTarget, Inc., SanDiego,
America) was added into the confluent cells and maintained
for 72 hours. The transduced cells were then selected for two
weeks using G418 (Sigma, New York, NY, USA). The trans-
duction efficiency and stability of the transduced cells were
then assessed qualitatively and quantitatively.
2.2. Animal Care. The animal study was approved by the
Committee on Use Live Animal for Teaching and Research
(CULATR3088-13),TheUniversity ofHongKong.The exper-
imental animal, male athymic Balb/c nude mice (Charles
River Lab, Wilmington, USA) were kept in the Laboratory
Animal Unit, The University of Hong Kong. Veterinarians
from the laboratory animal unit fed all mice with standard
rodent diet (LabDiet, St. Louis, USA) and autoclaved water
ad libitum and checked their general state. The feeding room
was maintained on a 12 : 12 hour light-dark circle at room
temperature, 16–22∘C. All animals were sacrificed 4 weeks
after cancer cell injection.
2.3. Xenograft of Cancer Cells. The cancer cell xenograft,
beforehand randomly allocated into 4 groups, was carried out
on four-week-old mice. Animals in group A, group B, group
C, and groupDwere injectedwithUM1,UM1-GFP,UM2, and
UM2-RFP cells, respectively (Table 1). A single dose of 0.3mL
PBS containing 1× 107 cancer cells was harvested and injected
subcutaneously at the inferior right dorsolateral site into the
mice immediately after the harvest.
2.4. Assessment of Tumorigenicity and Validity. The tumori-
genicity and validity of the fluorescence labelled cancer
Table 1: Xenograft of parental and transduced tongue cancer cells.
Animals Age (weeks) Cells Sacrifice time
A 8 4 UM1 Week 4
B 8 4 UM1-GFP Week 4
C 8 4 UM2 Week 4
D 8 4 UM2-RFP Week 4
cells in nude mice were assessed by physical examination,
imaging, and histologic examination.
Emerging xenograft tumors were physically examined,
measured in length and width, and recorded by the same
investigator (CWX). The tumor volume was calculated for
depicting a growth curve. A standard equation [11] was used
for the volume calculation: tumor volume= length×width2 ×
0.52.
The tumor take rate describes the percentage of mice that
develops a palpable tumor until the sacrifice time.
The fluorescence-positive tumors of the mice injected
with transduced cancer cells in groups B and D were
observed under the in vivo imaging system (IVIS) spectrum
(Perkin Elmer Inc., Waltham, USA) after being sacrificed by
intraperitoneal injection of 150mg/kg pentobarbital sodium
(Alfasan Diergeneesmiddelen BV, Woerden, Netherlands).
Tumor tissue and lungs of the mice in groups B and D
were harvested and examined.The results were recorded and
analysed using the Living Image 4.4 software (Perkin Elmer
Inc., Waltham, USA).
Fresh, unfixed lung and tumor tissue of groups B and
D animals underwent cryosection, to detect directly fluores-
cence labelled cancer cells. The specimens were immersed in
a 2 : 1 mixture of 20% sucrose (Electron Microscopy Science
EMS, Hatfield, USA) and Tissue-Tek optimum cutting
temperature (OCT) compound (EMS, Hatfield, USA) for 30
minutes, followed by another 30 minutes immersion in a
1 : 1 mixture of 20% sucrose and Tissue-Tek OCT compound.
Thereafter the specimens were embedded in Tissue-Tek OCT
compound in a tissuemold and frozen (EMS, Hatfield, USA).
The frozen specimens thenwere transferred onto ametal grid
and cut into tissue slices of 6𝜇m thickness in a cryostat, to
be finally observed under a fluorescence microscope (Nikon,
Tokyo, Japan). Harvested tumor tissue and lungs from mice
of groupsA andCwere fixed in 10%neutral formalin solution
and infiltrated in paraffin using Shandon Excelsior ESOper-
ator (Thermo Fisher Scientific Inc., Waltham, MA, USA).
The fixed tissue was cut with a microtome (Leica RM2155;
Nussloch, Germany) into 6𝜇m thick slices and histologically
examined under a light microscope (Leica DMLB, Nussloch,
Germany), after being stained with hematoxylin and eosin
(H&E).
2.5. Statistical Analysis. The SPSS version 20 (Chicago, IL,
USA) was used for statistical analyses. A nonparametric chi
square test was applied to compare the tumor take rate
between the different groups. The independent 𝑡-test was
used to compare themean tumor volume among the different
groups. Differences between groups have been considered to
be significant when 𝑝 ≤ 0.05.
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Figure 1: Tumor growth. The volume of the subcutaneous tumor
was measured at 8 time points (3, 7, 10, 14, 17, 21, 24, and 28 days after
cell injection) during the experiment. The mean tumor volume and
the standard deviation for all four groups are shown.
Table 2: Tumor take rate among the four groups (mean ± SD, %).
Group UM1 UM2 p value
Parental 100 (8/8) 50 (4/8) 0.021
Transduced 87.5 (7/8) 62.5 (5/8) 0.248
𝑝 value 0.302 0.615 —
3. Results
3.1. Physical Examination. The subcutaneously injected can-
cer cells thrived (Figure 1) and became physically palpable
tumors at the right posterior dorsolateral injection sites
(Figure 2). The tumor take rate of cancer cells and the tumor
volume of all four groups are summarized in Tables 2 and
3, respectively. The transduced cancer cell lines showed a
similar tumor take rate compared to their parental cancer
cells (𝑝 = 0.302 for UM1, 𝑝 = 0.615 for UM2). The tumor
volume between parental and transduced cell lines was not
significantly different (𝑝 = 0.501 for UM1, 𝑝 = 0.314 for
UM2).The tumor take rate (𝑝 = 0.021) and the tumor volume
(𝑝 = 0.003) emerged to be statistically significant between the
parental cell lines UM1 and UM2. Between the transduced
daughter cell lines UM1-GFP and UM2-RFP on the contrary,
the tumor take rate did not differ significantly (𝑝 = 0.248),
whereas the tumor volume differ highly significantly (𝑝 =
0.002).
3.2. In Vivo and Ex Vivo Fluorescent Imaging. Due to their
stable and intense signal transduced cancer cell lines could
be easily detected in the animals under fluorescent imaging
(Figure 3). Inmice of groups B (UM1-GFP inoculation) andD
(UM2-RFP inoculation) ex vivo fluorescent imaging detected
fluorescent signals in tumors, however, not in lung tissue
(Figure 3).
3.3. Histology. The cryosections of fresh tumor tissue har-
vested from groups B and D animals displayed clear signals
under the fluorescent microscope (Nikon TIRF microscope,
Table 3: Tumor volume among the four groups (mean ± SD, mm3).
Group UM1 UM2 p value
Parental 995.8 ± 558.4 72.4 ± 61.3 0.003
Transduced 822.5 ± 379.2 67.5 ± 59.0 0.002
𝑝 value 0.501 0.314 —
Nikon, Tokyo, Japan). Their histological properties could be
observed by fluorescent imaging obtained from cryosections.
Whereas tumors of the UM1-GFP cell lines displayed a
disorganized tissue structure with an aggressive invasion
front toward the surroundings (Figure 4(a)), tumors of the
UM2-RFP cell lines presented a well-defined mass with clear
borders (Figure 4(b)). Lung tissue of those mice exhibited no
fluorescent signals.
H&E stained UM1 cell line specimens showed poorly
differentiated tumor tissue with invasive growth patterns
(Figure 5(a)), while tumors of UM2 cell lines displayed
well differentiated features with well-defined cancer borders
(Figure 5(b)). Metastatic foci in H&E stained lung tissue
could not be found in any animal of whatsoever group.
4. Discussion
In vivo tumorigenicity of two subcutaneously injected fluo-
rescence labelled human tongue cancer cell lines of epithelial
and mesenchymal phenotype was verified and validated by
means of histopathologic examination and both in vitro and
in vivo imaging.
Nonprogress or even regression of xenografted cancer
represent an infringement of cancer cells in animal models
[12]. This experiment revealed a high tumor take rate (87.5%
for UM1-GFP, 62.5% for UM2-RFP) of transduced human
tongue cancer cell lines, whose fluorescent signals remained
stable in vivo until the expected time of euthanasia. Growth
patterns of fluorescent tumors were similar to those of the
parental, wild type, cell lines. Therefore, both similar tumor
take rate and volume between parental and transduced cell
lines verify the extant tumorigenicity of transduced human
tongue cancer cell lines.Moreover, histopathologic properties
of fluorescent cell lines were found to be similar to those
of the wild type cell lines and sustain together with the
tumorigenicity their validity in nude mice.
It is advocated that transformation from the epithelial
into the mesenchymal phenotype of cancer cells is important
both for local invasion and distant metastasis [8, 13–16]. The
mesenchymal phenotype of theUM1 cell line has already been
investigated and proven in vitro [17]; physical and histologic
findings of the here presented study point at its promoting
role in in vivo tumor formation and development.
The UM1 cell line presented (1) a higher tumor take
rate with an increased mean tumor volume and (2) a
propagated disorganization of its histopathologic growth
pattern, a correlation having been suggested before [18, 19].
Fluorescent imaging of the UM1-GFP cell line tumor further
depicted its invasive tumor front, supporting the validity of
the transduced UM1 cancer cell line in this study model.
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Figure 2: Subcutaneous tumor at injection site. Physically palpable tumor masses are shown which formed subcutaneously at the injection
site. The injected cells in each group (a) UM1; (b) UM2; (c) UM1-GFP; (d) UM2-RFP.
The lung was designated as the metastatic target organ in
the present study, because it was reported to be with 70% the
most frequently involved metastatic site [20]. The negative
result of lung metastases in this study, however, has to be
considered nonpersuasive because other potential organs
such as liver, brain, and bone have not been tested. Labelling
with two different colors provided an easy differentiation
between cancer cells of different phenotypes. Subcutaneous
injection of fluorescence labelled cancer cells in nude mice is
an established technique in cell cancer biology studies [21].
In this experimental setup, however, the inherent hetero-
geneity between subcutaneous space and tongue tissue might
represent a shortcoming. Future experiments with these cell
lines might benefit therefore from injection into the tongue
and hence from an orthotopic tumor model which probably
would be more persuasive.
A long-lasting fluorescent expression allows direct and
timely less limited imaging possibilities of in vivo cancer
development. Noninvasive whole-body imaging therefore
represents an appropriate monitoring of cancer growth and
progression [22]. Simultaneous application of GFP and
RFP in one animal is feasible due to distinct light spectra
between both colors [23]. Since cancer cells of epithelial
or mesenchymal phenotypes are long lastingly labelled with
distinct fluorescence, it may become feasible in the future to
simultaneously investigate cancer progression such as local
invasion and distant metastasis using both cell types in a
single animal model.
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Figure 3: In vivo and ex vivo fluorescent imaging of tumors and lung specimens. The inoculated tumors derived from UM1-GFP (a) and
UM2-RFP (b). Whereas the upper part of the image highlights the fluorescence in vivo, fluorescence of harvested tumor tissue and lung
specimens is shown in the lower part of the image.
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Figure 4: (a) Cryosection of a UM1-GFP tumor. The tumor presents a disorganized cell pattern (A) (magnification 40x) with an aggressive
invasion front (B) (magnification 20x). (b) Cryosection of a UM2-RFP tumor. A clear border (B) (magnification 20x) between well-defined
tumor cells (A) (magnification 40x) and the surrounding can be detected.
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Figure 5: (a) H&E staining of a UM1 tumor. (A) An invasive cancer pattern is shown at the front (black arrows, magnification 100x) of
UM1 derived cancer tissue. (B) Poor cell differentiation is observed within the tumor specimen (magnification 200x). (b) H&E staining of a
UM2 tumor. (A) A well-defined border to the surrounding tissue is visible (black arrows, magnification 100x). (b) The cancer tissue is well
differentiated (magnification 200x).
5. Conclusions
Long-lasting fluorescence labelling of epithelial and mes-
enchymal phenotype human tongue cancer cell lines does
not change neither tumorigenicity nor phenotype in vivo
and allows continuous monitoring by noninvasive in vivo
visualization.
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